摘要
目的探讨建立国境口岸接种不良反应(AEFI)监测体系。方法参照世界卫生组织(WHO)指南。回顾美国和加拿大 AEFI 监测模式,结合国境口岸工作实际,探讨如何建立国境口岸AE-兀监测体系。结果口岸 AEFI 监测体系应采取被动监测模式。与国家食品药品监督管理局的药品不良反应监测体系保持良好的协作机制。同时保持一定独立性;以下几方面是确保监测体系良性运行的关键因素:专业人员和专家队伍、数据信息的收集和分析、充足的资源配置、体系的效率、对外沟通机制、鼓励 AEFI 报告的宽松环境。结论应建立国境口岸统一的 AEFI 监测体系。整合资源。逐步铺开有助于建立口岸统一的 AEFI 监测体系。
Objective To discuss principle on developing a surveillance system for adverse events following im- munization(AEFI)at frontier port. Method To establish a surveillance system for AEFI at frontier port,with Guideline from WHO and surveillance models for AEFI in U.S.A and Canada being reviewed,proposals on development of surveillance system for AEFI is generalized. Results With good liaison mechanisms with national drug monitoring unit,AEFI at frontier port should be independently monitored by passive surveillance system.Factors critical to the success of the surveillance system include as below:professionalism and expertise,data collection and analysis information,adequate resources,efficiency,communication,an ethos of encouraging medical staff to report AEFI. Conclusion To develop a surveillance system for AEFI at frontier port step by step,resources should be reorganized.
